KLK3 and prostate adenocarcinoma: Later, in 2006, Logan et al. confirmed Pirh2–AR interaction and demonstrated that Pirh2 is recruited to the ARE (androgen response element) of the PSA (prostate-specific antigen) coding gene enhancing AR-mediated PSA expression activation in human prostate adenocarcinoma cells [167].